Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic
Todd Logan, Matthew Simon, Amit Kumar Rana, et al.
Cell (2021) Vol. 184, Iss. 18, pp. 4651-4668.e25
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

The different autophagy degradation pathways and neurodegeneration
Angeleen Fleming, Mathieu Bourdenx, Motoki Fujimaki, et al.
Neuron (2022) Vol. 110, Iss. 6, pp. 935-966
Open Access | Times Cited: 294
Emerging roles of innate and adaptive immunity in Alzheimer’s disease
Xiaoying Chen, David M. Holtzman
Immunity (2022) Vol. 55, Iss. 12, pp. 2236-2254
Open Access | Times Cited: 164
Designing antibodies as therapeutics
Paul J. Carter, Arvind Rajpal
Cell (2022) Vol. 185, Iss. 15, pp. 2789-2805
Open Access | Times Cited: 137
Lysosomal dysfunction in neurodegeneration: emerging concepts and methods
Vinod Udayar, Yu Chen, Ellen Sidransky, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 3, pp. 184-199
Open Access | Times Cited: 128
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
Bettina van Lengerich, Lihong Zhan, Dan Xia, et al.
Nature Neuroscience (2023)
Open Access | Times Cited: 128
Progranulin as a therapeutic target in neurodegenerative diseases
Hervé Rhinn, Nadine Tatton, Stella McCaughey, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 8, pp. 641-652
Open Access | Times Cited: 118
Advancing cell therapy for neurodegenerative diseases
Sally Temple
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 512-529
Open Access | Times Cited: 90
Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia
Dan Xia, Steve Lianoglou, Thomas Sandmann, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 71
Frontotemporal lobar degeneration
Murray Grossman, William W. Seeley, Adam L. Boxer, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 65
Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist
Alexandra Litvinchuk, Jung H. Suh, Jing Guo, et al.
Neuron (2023) Vol. 112, Iss. 3, pp. 384-403.e8
Open Access | Times Cited: 59
Mechanisms of autophagy–lysosome dysfunction in neurodegenerative diseases
Ralph A. Nixon, David C. Rubinsztein
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 11, pp. 926-946
Closed Access | Times Cited: 47
Lysosomal damage sensing and lysophagy initiation by SPG20-ITCH
Pinki Gahlot, Bojana Kravić, Giulia Rota, et al.
Molecular Cell (2024) Vol. 84, Iss. 8, pp. 1556-1569.e10
Open Access | Times Cited: 23
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 760
Closed Access | Times Cited: 19
TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia
Jordan D. Marks, Virginia Estades Ayuso, Yari Carlomagno, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 730
Open Access | Times Cited: 17
The Endo-Lysosomal Damage Response
Hemmo Meyer, Bojana Kravić
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 367-387
Closed Access | Times Cited: 15
ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signaling
William Hancock‐Cerutti, Zheng Wu, Peng Xu, et al.
The Journal of Cell Biology (2022) Vol. 221, Iss. 7
Open Access | Times Cited: 67
Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis
Sebastian Boland, Sharan Swarup, Yohannes Abere Ambaw, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 60
Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia
Matthew Simon, Todd Logan, Sarah L. DeVos, et al.
Trends in Cell Biology (2022) Vol. 33, Iss. 4, pp. 324-339
Open Access | Times Cited: 55
Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency
Anika Reifschneider, Sophie Robinson, Bettina van Lengerich, et al.
The EMBO Journal (2022) Vol. 41, Iss. 4
Open Access | Times Cited: 53
Microglial efferocytosis: Diving into the Alzheimer’s disease gene pool
Carmen Romero‐Molina, Francesca Garretti, Shea J. Andrews, et al.
Neuron (2022) Vol. 110, Iss. 21, pp. 3513-3533
Open Access | Times Cited: 53
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments
Matthew E. Gegg, Elisa Menozzi, Anthony H.V. Schapira
Neurobiology of Disease (2022) Vol. 166, pp. 105663-105663
Open Access | Times Cited: 48
CD98hc is a target for brain delivery of biotherapeutics
Kylie S. Chew, Robert C. Wells, Arash Moshkforoush, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 36
The Batten disease gene product CLN5 is the lysosomal bis(monoacylglycero)phosphate synthase
Uche N. Medoh, Andy Hims, Julie Y. Chen, et al.
Science (2023) Vol. 381, Iss. 6663, pp. 1182-1189
Closed Access | Times Cited: 33
Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood-brain barrier crossing by engineered viral vectors
Timothy F. Shay, Erin E. Sullivan, Xiaozhe Ding, et al.
Science Advances (2023) Vol. 9, Iss. 16
Open Access | Times Cited: 28
Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents
Yachao He, Ibrahim Kaya, Mohammadreza Shariatgorji, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top